Matches in SemOpenAlex for { <https://semopenalex.org/work/W2274092970> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2274092970 endingPage "398" @default.
- W2274092970 startingPage "394" @default.
- W2274092970 abstract "Objective: To investigate the antidepressant effect of selective alpha2-adrenoceptor blockade in mice. Methods:The study was done in Laka mice employing forced swimming-induced despair behaviour as test model. They were acutely treated with dose of 0.25, 0.5, 1 and 2 mg/kg, SC and effect of 1 mg/kg of idazoxan was seen at different time intervals of 15,30, 60 and 120 min.The reversal of effect of idazoxan by reserpine (2 mglkg, ip), isoprenaline (8 mg/kg, ip) and clonidine (0.15 mglkg, ip) was also studied. The antidepressant effect of idazoxan (1 mgikg) was compared with imipramine (10 mg/kg, ip) and fluoxetine (10 mg/kg, ip) in acute study and with imipramine (10 mglkg, ip) in chronic study. Duration of immobility in seconds during the 6 min test session was recorded and used to assess the antidepressant effect. Results: ldazoxan produced antidepressant effect in a dose dependent manner with maximum effect observed at 30 min. Prior administration of idazoxan (1 mg/kg) reversed isoprenaline- and clonidine-induced increase in immobility time. Further, the chronic idazoxan treatment (1 mg/kg x 9 d) reversed isoprenaline-induced despair behaviour but the effect was not statistically significant. Also the dose of 0.5 and 2 mgikg of idazoxan did not reverse clonidine (0.15 mg/kg) induced increased immobility time. ldazoxan also reversed reserpine (2 mg/kg) -induced despair behaviour after 4 h and 24 h. In acute study, idazoxan (1 mg/kg) produced significant and better effect as compared to imipramine and fluoxetine. The chronic effect of idazoxan was also more pronounced than chronic imipramine treatment. Conclusion: The results of the present study indicate involvement of presynaptic alpha2-adrenoceptors in the antidepressant effect of idazoxan." @default.
- W2274092970 created "2016-06-24" @default.
- W2274092970 creator A5035813233 @default.
- W2274092970 creator A5046951426 @default.
- W2274092970 date "1998-10-08" @default.
- W2274092970 modified "2023-09-24" @default.
- W2274092970 title "SELECTIVE ALPHA2: ADRENOCEPTOR BLOCKADE PRODUCES ANTIDEPRESSANT EFFECT IN MICE" @default.
- W2274092970 hasPublicationYear "1998" @default.
- W2274092970 type Work @default.
- W2274092970 sameAs 2274092970 @default.
- W2274092970 citedByCount "2" @default.
- W2274092970 countsByYear W22740929702014 @default.
- W2274092970 crossrefType "journal-article" @default.
- W2274092970 hasAuthorship W2274092970A5035813233 @default.
- W2274092970 hasAuthorship W2274092970A5046951426 @default.
- W2274092970 hasConcept C126322002 @default.
- W2274092970 hasConcept C134018914 @default.
- W2274092970 hasConcept C136569192 @default.
- W2274092970 hasConcept C142724271 @default.
- W2274092970 hasConcept C170493617 @default.
- W2274092970 hasConcept C185592680 @default.
- W2274092970 hasConcept C204787440 @default.
- W2274092970 hasConcept C24998067 @default.
- W2274092970 hasConcept C2776090920 @default.
- W2274092970 hasConcept C2776885963 @default.
- W2274092970 hasConcept C2777842393 @default.
- W2274092970 hasConcept C2778399450 @default.
- W2274092970 hasConcept C2779145073 @default.
- W2274092970 hasConcept C2779177272 @default.
- W2274092970 hasConcept C2780648677 @default.
- W2274092970 hasConcept C2780939551 @default.
- W2274092970 hasConcept C2781161787 @default.
- W2274092970 hasConcept C71924100 @default.
- W2274092970 hasConceptScore W2274092970C126322002 @default.
- W2274092970 hasConceptScore W2274092970C134018914 @default.
- W2274092970 hasConceptScore W2274092970C136569192 @default.
- W2274092970 hasConceptScore W2274092970C142724271 @default.
- W2274092970 hasConceptScore W2274092970C170493617 @default.
- W2274092970 hasConceptScore W2274092970C185592680 @default.
- W2274092970 hasConceptScore W2274092970C204787440 @default.
- W2274092970 hasConceptScore W2274092970C24998067 @default.
- W2274092970 hasConceptScore W2274092970C2776090920 @default.
- W2274092970 hasConceptScore W2274092970C2776885963 @default.
- W2274092970 hasConceptScore W2274092970C2777842393 @default.
- W2274092970 hasConceptScore W2274092970C2778399450 @default.
- W2274092970 hasConceptScore W2274092970C2779145073 @default.
- W2274092970 hasConceptScore W2274092970C2779177272 @default.
- W2274092970 hasConceptScore W2274092970C2780648677 @default.
- W2274092970 hasConceptScore W2274092970C2780939551 @default.
- W2274092970 hasConceptScore W2274092970C2781161787 @default.
- W2274092970 hasConceptScore W2274092970C71924100 @default.
- W2274092970 hasIssue "6" @default.
- W2274092970 hasLocation W22740929701 @default.
- W2274092970 hasOpenAccess W2274092970 @default.
- W2274092970 hasPrimaryLocation W22740929701 @default.
- W2274092970 hasRelatedWork W1969454122 @default.
- W2274092970 hasRelatedWork W1976824192 @default.
- W2274092970 hasRelatedWork W2009892897 @default.
- W2274092970 hasRelatedWork W2010575424 @default.
- W2274092970 hasRelatedWork W2017830858 @default.
- W2274092970 hasRelatedWork W2036786565 @default.
- W2274092970 hasRelatedWork W2042757124 @default.
- W2274092970 hasRelatedWork W2061369903 @default.
- W2274092970 hasRelatedWork W2077655803 @default.
- W2274092970 hasRelatedWork W2093869050 @default.
- W2274092970 hasRelatedWork W2094461955 @default.
- W2274092970 hasRelatedWork W2151899047 @default.
- W2274092970 hasRelatedWork W2244933428 @default.
- W2274092970 hasRelatedWork W2365158726 @default.
- W2274092970 hasRelatedWork W2376825516 @default.
- W2274092970 hasRelatedWork W2413620091 @default.
- W2274092970 hasRelatedWork W2415751437 @default.
- W2274092970 hasRelatedWork W2418307647 @default.
- W2274092970 hasRelatedWork W2407060995 @default.
- W2274092970 hasRelatedWork W2802801166 @default.
- W2274092970 hasVolume "30" @default.
- W2274092970 isParatext "false" @default.
- W2274092970 isRetracted "false" @default.
- W2274092970 magId "2274092970" @default.
- W2274092970 workType "article" @default.